Auburn CVM Receives $1.7M Award as a Center for Translational Cancer Nanomedicine
In September the U.S. Department of Health and Human Services, through the National Institutes of Health (NIH), notified Dr. Valery Petrenko, Professor in the Department of Pathobiology, that he and his laboratory had competed successfully for recognition as a Center for Translational Cancer Nanomedicine. The five-year $1.7 million award is part of a larger, $13 million collaborative, inter-institutional initiative recognized by the National Nanotechology Initiative sponsored by NIH as a new Center for Cancer Nanotechnology Excellence. Dr. Petrenko and his group will work with scientists at Northeastern University and Harvard Medical School. The group will develop new, nanotechnology-based strategies for treatment of lung, pancreatic, and breast cancers. Studies will involve both the design and testing of new nano-therapeutic strategies and related delivery systems.